Contact Us
Company Overview
|
Pipeline / Clinical Trials
|
Science & Discovery
|
Business Development
|
Investors
Overview
|
Stock Data
|
Governance
|
SEC Filings
|
News & Events
|
Presentations
|
Fundamentals
|
Information Request
Press Release Archive
Press Release Archive
2010
>
2009
>
2008
>
2007
>
2006
>
2005
>
2004
>
2003
> 2002 >
2001
December 19, 2002
RegeneRx to Begin Human Clinical Trials For Novel Wound Healing Drug
December 5, 2002
RegeneRx Files for Orphan Drug Designation For Thymosin Beta 4
November 18, 2002
RegeneRx Files Investigational New Drug Application for Thymosin Beta 4
September 30, 2002
News Study Shows RegeneRx's Tß4 Stimulates Migration and Production of Key Molecule Necessary for Eye Repair
September 26, 2002
RegeneRx to Present at Annual Techvest Healthcare Conference
June 28, 2002
RegeneRx Adds Richard Hindin to Board of Directors
June 3, 2002
RegeneRx's Drug Effectively Enhances Wound Repair In Diabetic Animals
May 2, 2002
New Link Between RegeneRx's Thymosin ßeta 4 And Wound Healing Reported
April 12, 2002
News Study Confirms RegeneRx's Tß4 Accelerates Healing of Eye Wounds
April 4, 2002
RegeneRx Reports 2001 Financial Results
March 19, 2002
RegeneRx Appoints J.J. Finkelstein as President, CEO & Director
March 11, 2002
RegeneRx Receives $1.7 Million Private Equity Investment
home
|
Contact Us
|
Resources
|
Site Map
|
Search
